title: Prospective study on the application of the Baveno II Consensus Conference criteria in patients with cirrhosis and gastrointestinal bleeding.
abstract: OBJECTIVE
  This study aimed to evaluate the Baveno II criteria defining key events in variceal bleeding.
  
  
  METHODS
  These criteria were applied to 196 patients with cirrhosis admitted for upper gastrointestinal bleeding due to portal hypertension and enrolled in a trial. Blood pressure, heart rate, hematocrit and clinical signs of upper digestive tract hemorrhage were recorded for 5 days. The blind overall clinical judgment of hemodynamic stability was recorded separately by the Steering Committee.
  
  
  RESULTS
  The evaluation of several hemodynamic criteria was left to the judgment of the clinician. The first time point for the control of bleeding, fixed at 6 h after admission, was impractical since 13% of the patients had not yet received specific treatment. The independent judgment did not agree in 38% of 82 cases without control of bleeding. In 15% of cases this was due to tachycardia. Calculation of several judgment criteria was not defined in the Baveno II criteria: survival without bleeding at 5 days, transfusion rate, and length of hospital stay.
  
  
  CONCLUSIONS
  Although the Baveno II criteria have improved the definitions of key events, the criteria are hampered by limits such as false positive criteria of failure to control bleeding. We make several proposals for improvement.
authors.affiliation: The French Club for the Study of Portal Hypertension, Service d'Hepato-Gastroenterologie, CHU, Angers. Paul.Cales@med.univ-angers.fr
authors.forename: P
authors.initials: P
authors.lastname: Calès
authors.forename: N
authors.initials: N
authors.lastname: Lacave
authors.forename: C
authors.initials: C
authors.lastname: Silvain
authors.forename: J P
authors.initials: JP
authors.lastname: Vinel
authors.forename: K
authors.initials: K
authors.lastname: Besseghir
authors.forename: D
authors.initials: D
authors.lastname: Lebrec
mesh_terms: D001803:Blood Transfusion; D004311:Double-Blind Method; D006471:Gastrointestinal Hemorrhage / Q000628:therapy*; D006801:Humans; D007902:Length of Stay; D015993:Life Tables; D008103:Liver Cirrhosis / Q000150:complications*; D011446:Prospective Studies; D013610:Tachycardia / Q000628:therapy; D017211:Treatment Failure